Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression

Registry ID

EUCTR2007-004513-33

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

University of Oxford

Start date

2008-05-08

Completion date

2013-04-27

Last update

2026-08-16

Conditions

• Bipolar depression

Summary

To evaluate the relative efficacy of combination therapy with quetiapine plus lamotrigine and quetiapine monotherapy plus lamotrigine placebo in terms of improvement in depressive symptoms at 12 weeks in patients with bipolar depressive disorder.

Locations

• , , UK

Related clinical trials

• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.

View on source registry